Markets · 1 sources covering this

Week of Whiplash in Treasuries Is Closing With Traders on Pause

After a turbulent stretch for the US bond market, traders are heading into Friday’s session with questions about what Treasury Secretary Scott Bessent’s next move will be.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·1h ago
Week of Whiplash in Treasuries Is Closing With Traders on Pause
After a turbulent stretch for the US bond market, traders are heading into Friday’s session with questions about what Treasury Secretary Scott Bessent’s next move will be.
Read at Bloomberg →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/0a0d8b700da044837608fe9e091c188219219a3d"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Week of Whiplash in Treasuries Is Closing With Traders on Pause"></iframe>

Week of Whiplash in Treasuries Is Closing With Traders on Pause

How 1 sources are covering this

Week of Whiplash in Treasuries Is Closing With Traders on Pause

More from Markets

German Manufacturing Boost, French Businesses Hit By Heatwave | The Pulse 8/21/2026

MLB Labor Dispute Drives Record Short Interest in Braves Stock

Moderna’s personalized mRNA shot could reshape the fight against skin cancer — but it may also be overhyped

US Stock Futures Gain as Nasdaq 100 Looks to Snap Five-Day Slump

Reader

Trust & legal

Across the network

How 1 sources are covering this

Week of Whiplash in Treasuries Is Closing With Traders on Pause

More from Markets

German Manufacturing Boost, French Businesses Hit By Heatwave | The Pulse 8/21/2026

MLB Labor Dispute Drives Record Short Interest in Braves Stock

Moderna&#x2019;s personalized mRNA shot could reshape the fight against skin cancer &#x2014; but it may also be overhyped

US Stock Futures Gain as Nasdaq 100 Looks to Snap Five-Day Slump

Reader

Trust & legal

Across the network

Moderna’s personalized mRNA shot could reshape the fight against skin cancer — but it may also be overhyped